Cancer Communications
indexed by SCI
BMC


Original article
PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer
Trine Vilsboll Larsen, Dianna Hussmann and Anders Lade Nielsen
Cancer Communications 2019 39: 30
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/3/2019   doi:10.1186/s40880-019-0376-6
Original article
Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)
Ji-Yeon Kim, Seri Park, Seock-Ah Im, Sung-Bae Kim, Joohyuk Sohn, Keun Seok Lee, Yee Soo Chae, Ki Hyeong Lee, Jee Hyun Kim, Young-Hyuck Im, Tae-Yong Kim, Kyung-Hun Lee, Jin-Hee Ahn, Gun Min Kim, In Hae Park, Soo Jung Lee, Hye Sook Han, Se Hyun Kim, Kyung Hae Jung, Yeon Hee Park and Korean Cancer Study Group
Cancer Communications 2019 39: 29
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 5/28/2019   doi:10.1186/s40880-019-0375-7
Original article
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type
Yuankai Shi, Jin Li, Jianming Xu, Yan Sun, Liwei Wang, Ying Cheng, Wei Liu, Guoping Sun, Yigui Chen, Li Bai, Yiping Zhang, Xiaohui He, Yi Luo, Zhehai Wang, Yunpeng Liu, Qiang Yao, Yuhong Li, Shukui Qin, Xiaohua Hu, Feng Bi, Rongsheng Zheng and Xuenong Ouyang
Cancer Communications 2019 39: 28
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 5/24/2019   doi:10.1186/s40880-019-0374-8
Letter to the Editor
Is cancer-related death associated with circadian rhythm?
Shing Fung Lee and Miguel Angel Luque-Fernandez
Cancer Communications 2019 39: 27
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 5/14/2019   doi:10.1186/s40880-019-0373-9
Original article
The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer
Zhi-Qiang Wang, Fei Zhang, Ting Deng, Le Zhang, Fen Feng, Feng-Hua Wang, Wei Wang, De-Shen Wang, Hui-Yan Luo, Rui-Hua Xu, Yi Ba and Yu-Hong Li
Cancer Communications 2019 39: 26
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 5/8/2019   doi:10.1186/s40880-019-0367-7
Original article
Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
Jin Wang, Hailin Tang, Xing Li, Cailu Song, Zhenchong Xiong, Xi Wang, Xiaoming Xie and Jun Tang
Cancer Communications 2019 39: 25
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 5/8/2019   doi:10.1186/s40880-019-0371-y
Original article
National trend of gastric cancer mortality in China (2003-2015): a population-based study
Kun Gao and Jun Wu
Cancer Communications 2019 39: 24
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 5/2/2019   doi:10.1186/s40880-019-0372-x
Original article
Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance
Wai Hoong Chang, Donall Forde and Alvina G. Lai
Cancer Communications 2019 39: 23
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 4/29/2019   doi:10.1186/s40880-019-0369-5
Short report
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Rui-Mei Feng, Yi-Nan Zong, Su-Mei Cao and Rui-Hua Xu
Cancer Communications 2019 39: 22
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 4/29/2019   doi:10.1186/s40880-019-0368-6
Review
Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer
Tong Wu, Xuan Wu, Hong-Yang Wang and Lei Chen
Cancer Communications 2019 39: 21
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 4/18/2019   doi:10.1186/s40880-019-0365-9

<<    Page 1 of 19  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts Editorial Manager to manage its submissions from Dec.18, 2014

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by BioMed Central

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China